We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$2.9B
AUM Growth
-$179M
Cap. Flow
-$339M
Cap. Flow %
-11.66%
Top 10 Hldgs %
11.95%
Holding
1,370
New
136
Increased
551
Reduced
477
Closed
195

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$15.7M
2
PM icon
Philip Morris
PM
+$13.6M
3
MO icon
Altria Group
MO
+$13.4M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$12.7M
5
HUBB icon
Hubbell
HUBB
+$8.92M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$61.6M
2
V icon
Visa
V
+$20.6M
3
ADBE icon
Adobe
ADBE
+$13.8M
4
ACN icon
Accenture
ACN
+$12.5M
5
PCAR icon
PACCAR
PCAR
+$9.72M

Sector Composition

Rank Sector Weight
1 Technology 23.85%
2 Healthcare 13.07%
3 Industrials 12.02%
4 Consumer Discretionary 10.67%
5 Financials 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NNN icon
1301
NNN REIT
NNN
$9.33B
– –
-11,978
Closed -$529K
NOV icon
1302
NOV
NOV
$7.46B
– –
-64,685
Closed -$1.2M
NTRS icon
1303
Northern Trust
NTRS
$22.2B
– –
-6,233
Closed -$549K
NVCR icon
1304
NovoCure
NVCR
$2.17B
– –
-6,621
Closed -$398K
NWL icon
1305
Newell Brands
NWL
$2.14B
– –
-23,139
Closed -$288K
OGN icon
1306
Organon & Co
OGN
$3.56B
– –
-12,344
Closed -$290K
OPEN icon
1307
Opendoor
OPEN
$3.71B
– –
-13,450
Closed -$22.9K
ORGO icon
1308
Organogenesis Holdings
ORGO
$308M
– –
-33,694
Closed -$71.8K
PBI icon
1309
Pitney Bowes
PBI
$2.43B
– –
-19,018
Closed -$74K
PDBC icon
1310
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$5.81B
– –
-67,159
Closed -$955K
PII icon
1311
Polaris
PII
$4.13B
– –
-72,810
Closed -$8.05M
PRDO icon
1312
Perdoceo Education
PRDO
$1.93B
– –
-13,073
Closed -$176K
PVH icon
1313
PVH
PVH
$3.64B
– –
-5,866
Closed -$523K
QDEL icon
1314
QuidelOrtho
QDEL
$1.11B
– –
-2,349
Closed -$209K
QGEN icon
1315
Qiagen
QGEN
$8.53B
– –
-5,680
Closed -$277K
RAPT
1316
DELISTED
RAPT Therapeutics
RAPT
– –
-4,924
Closed -$723K
RCI icon
1317
Rogers Communications
RCI
$17.7B
– –
-11,213
Closed -$519K
RCUS icon
1318
Arcus Biosciences
RCUS
$3.64B
– –
-23,276
Closed -$425K
REPL icon
1319
Replimune Group
REPL
$839M
– –
-26,161
Closed -$462K
RY icon
1320
Royal Bank of Canada
RY
$291B
– –
-27,959
Closed -$2.69M
SABR icon
1321
Sabre
SABR
$660M
– –
-29,080
Closed -$125K
SATX
1322
DELISTED
SatixFy Communications
SATX
– –
-24,237
Closed -$16.5K
SBCF icon
1323
Seacoast Banking Corp of Florida
SBCF
$3.23B
– –
-31,062
Closed -$736K
SCI icon
1324
Service Corp International
SCI
$11.1B
– –
-8,903
Closed -$612K
SGMO
1325
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-33,486
Closed -$58.9K
51 52
53
54 55

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
WI
Winder Investment Singapore $4.4B AUM 8.87% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return

Vident Investment Advisory's Q2 2023 Portfolio in Review

As of Q2 2023, Vident Investment Advisory held 1,370 positions worth $2.9B, down 5.8% from $3.08B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Vident Investment Advisory withdrew a net $339M in Q2 2023, closing 195 positions and reducing 477 holdings. Its most notable exit was Polaris, an estimated $8.05M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Vident Investment Advisory opened a new position in Hubbell worth $10.7M.

  • Vident Investment Advisory's largest Q2 2023 buy was Hubbell: 32,210 shares worth $10.7M.
  • Vident Investment Advisory added most to T-Mobile US in Q2 2023, an estimated $15.7M increase.
  • Vident Investment Advisory's biggest Q2 2023 reduction was Apple, cutting an estimated $61.6M.
  • Vident Investment Advisory fully exited Polaris in Q2 2023, selling an estimated $8.05M.
  • Vident Investment Advisory's ten largest holdings make up 12% of its $2.9B portfolio in Q2 2023.
  • Vident Investment Advisory opened 136 new positions and closed 195 in Q2 2023.
  • Vident Investment Advisory's portfolio value fell 5.8% quarter-over-quarter to $2.9B.

Based on Vident Investment Advisory's 13F filing for Q2 2023, filed 11 Aug 2023.